quantitative polymerase chain reaction method to measure induction of a retinoic acid responsive gene, cytoplasmic retinoic acid binding protein II, has made it possible to generate objective data suitable for investigations of drug efficacy. This method of using grafted human skin has potential broad applicability for investigation of topical drugs in a number of therapeutic fields. J Invest Dermatol1 02: 515 -518, 1994 type specific to skin [15 ,16] . Recently, measurements of the steadystate levels of CRABPII mRNA have been proposed as a selective marker for cutaneous retinoid activity in vivo [6, [16] [17] [18] ' The effects of RA on human skin have been previously studied using epidermal (keratome) biopsies from human volunteers treated with retinoids. Cultured keratinocytes or dermal fibroblasts have been of limited usefulness because the response of markers in cultured cells often contrasts sharply with data from studies on intact skin [13, 19, 20] . To overcome this disparity, and to allow collection of data on human tissue without treating human volunteers, we felt the development of the human skin -grafted nude mouse model was particularly appropriate.
MATERIALS AND METHODS
Skin Transpl~ntation Nude mice (Balb/C, male and female) at 6 weeks old were obtamed from Charles River Inc. and kept in a pathogen-free colony. MI~e were anesthetized by intraperitoneal injection with tribromoethanolm tertiary amyl alcohol (Avertine) as described [21] . For human skin (1 X 1 cm) to be grafted onto the mouse body, a.graft bed of similar size at the upper left shoulder of the mouse was prepared by removing the full-thickness skm down to the fascia. Full-thickness human breast skin grafts (obtained with patient co nsent and approval of the administration of York-Finch General Hospital, Toronto) were either dermatomed or sliced out manually. The subcutaneous tissue was removed. Human skin grafts were then placed on the graft bed and held in place with a petroleum-gel coated Band-Aid wrapped around the circumference of the mouse thorax. The Band-Aid was stapled on the ventral side of the mouse. For small skin sections to be grafted onto the mouse tails, mouse skin (3 X 10 mm) near the base was carefully peeled off with the aid of a scalpel blade to avoid bleeding. Human skin of similar size was then placed over the graft site, lightly sprayed with liquid Band-aid, and protected with a pl astic tube taped in place. BandAids or tubes were removed after 7 -1 0 d and grafts were allowed to heal for an additional 1 -2 weeks before drug treatment.
Experimental Protocols Fully healed grafts were treated once daily for 4 d with 15 ,ul of70% ethanolj30% propylene glycol vehicle containing the indicated concentration of all-trans RA (Sigma). Mice were sacrificed on day 5 and the grafts removed for analysis. A 2 X 10 mm slice through the full thickness of each graft was transferred to OCT freezing compound and frozen for later histologic analysis. The remainder of the grafted tissue was used for RNA preparation. In the case of smaller grafts on the tail site, 5 ,ul of drug so lution was applied and the entire graft used for either histologic examination or RNA preparation.
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Histologic and Immunohistochemical Staining Serial 5-)1m sections were cut from both frozen and paraformaldehyde-fixed/paraffin-embedded tissue. For routine histologic examination, paraffin sections were dewaxed and hydrated through several washes of toluene and graded e~hanols, fo llowed by staining with hcmatoxylll1-eosll1 .. Immuno~lstochem.lcal met!lOds were used to detect various markers of epidermal differentiation In either paraffin-fixed or frozen sections. Paraffin-fixed sections [22] were dig.ested 10 min with pepsin and Il1cubated for 2 h with mouse monoclonal antibodies against human K~O (ESBE Laboratories, dilut~d 1/200) or K13 (Biogenex Laboratories~ diluted 1/20) or with human-ll1volucnn specific. rabbit antiserum (Biomedical Technologies Inc., diluted 1/4) followed by blOtlnylated goat anti-rabbit IgG (Zymed, 1/200 dilution, 30 min) and streptavidin-conjugated horse radish peroxidase (Dako, 1/300 dilution, 30 min) and stained with 3-amino-9-ethyl-carbazole. Epidermal transglutaminase and filaggrin expression was examined in frozen sections [23] incubated with mouse monoclonal antibodies specific for human keratinocyte transglutaminase (Biomedical Technologies Inc., pre-diluted, 2 h incubation) or human filaggrin (Biomedical Technologies Inc., 1/1000 dilution, overnight at 4 0 C) followed by biotinylated goat anti-mouse IgG (Zymed, 1/200, 30 min) and streptavidin-conjugated alkaline phosphatase (Dako, 1/200,30 min), and stained with New Fuschin. All antibody incubations were at room temperature unless otherwise stated.
Quantitative Analysis RNA was prepared from pulverized, frozen skin using the method of Chomczynski and Sacchi [24] . Human RNA from grafted skin was quantitated relative to an RNA sample from non-grafted human skin by measurement of trich loroacetic acid (TCA)-precipitable counts generated in a reverse-transcriptase reaction using human-specific primers for glycerol 3-phosphate dehydrogenase (G3PDH). The sequence of the human G3PDH primer used in the RT -TCA precipitation analysis is 5'-CATGTGGGCCATGAGGTCCACCAC (Clonetech). Briefly, 1)11 of RNA was reverse transcribed in a 20)11 reaction as described previously [6] with the exception that 5 )1Ci oP2P-dCTP was used to label the synthesized cDNA. Five microliters of the resulting mixture was added to 300 )11 of 4 mg/ml herring sperm DNA (carrier) and precipitated with 3 ml of cold 5% TCA (w Iv). Precipitated cDNA was collected on a Whatman 934 AH glass fiber filter, washed extensively with cold 95% ethanol and the amount of incorporated radioactivity determined by liquid scintillation counting. All reactions were carried out in triplicate. The amount of human RNA within the graft preparations was quantitated relative to a sample of control human skin RNA whose concentration was known. Quantitative RT-PCR for human CRABPII RNA was carried out as described [6] . A human CRABPII specific primer (5'-CAGTGAAGCAGGGCGGTGAGCAT [CRB-4]) was used for the RT reaction to ensure that only human mRNA could serve as a template for the reaction. The primers used for the PCR step were CRB-1 (S'-GGCAACTGGAAAATCATCCGATCGGAAAAG) and CRB-2 (5'-CACTCTCCCATTTCACCAGGCTCTTACAG); these primers are 96% and 93% identical to the corresponding mouse cDNA sequences and are not capable of distinguishing between mouse and human cDNA under our PCR conditions.
RESULTS
Skin Grafts Full-thickness human skin was obtained from three patients during the de-epithelialization stage of reduction mammography. Two methods of skin grafting were used, both yielding similar results. Grafts of 1-2 cm 2 were placed on the back of the mouse. Smaller grafts (about 0.5 cm 2 ) placed at the base of the tail were sometimes used with similar results. Successful grafts were obtained in over 70% of mice transplanted. Graft failures were of technical origin, never resembling the rypical course of immunologic rejection characteristic of non-immunodeficient mice. The graft/mouse junction was easy to identify visually by the greater thickness and different pigmentation of human skin.
Histologic Analysis Detailed histologic analysis ;as carried out on 16 independent grafts plus a sample of non-grafted skin, all derived from a single patient. The grafts were divided into four groups and treated with vehicle (ethanol/propylene glycol), 0.01 % RA, 0.03% RA, or 0.10% RA. No outward sign of biologic activiry, such as erythema or scaling, was noticeable in any treatment groups. Upon completion of treatment, mice were sacrificed by cervical dislocation and grafts were removed for routine histologic staining and immunohistochemistry. ited a normal morphologic appearance, with preservation of rete ridges and a stratified pattern of epidermal differentiation (basal, spinous, and granular layers, as well as stratum corneum) that was indistinguishable from histologic samples of non-grafted human breast skin derived from the same individual (data not shown). Mouse and human epidermis could readily be distinguished by differences in structure and thickness. The RA-treated skin graft exhibited the expected histologic changes associated with topical RA treatment: compacting of the stratum corneum, epidermal thickening, and parakeratosis, evident even at the lowest concentration tested [13] .
Markers of epidermal differentiation were also examined in skin grafts using immunocytochemical analysis. These included keratins Ki0 and K13, cornified envelope proteins involucrin and filaggrin, and epidermal transglutaminase (transglutaminase K, a membranebound, keratinocyte-specific trans glutaminase responsible for crosslinking of the envelope proteins). Previous studies have shown that involucrin, filaggrin, and transglutaminase expression patterns are al tered in vivo by RA treatment, whereas K10 is unchanged [13, 20] . K13, normally present only in non-keratinized epithelia, was reported to be focally expressed in the suprabasallayers of epidermis in a small number of patients [13] . With these epidermal differentiation markers, we showed that grafted human skin exhibited responses similar to those described in human subjects treated with topical RA [13] . K10 was unchanged and no specific K13 staining was found in any of the samples tested (data not shown). In contr~st, a dramat~c increase of im:,olucrin expression was observed (FIg 1A) ; tillS ll1cr~ased expressIOn .was already maximal at the lowest RA concentratIOn tested. In velucletreated skin grafts, involucrin is localized in a narrow band just below the stratum corneum, whereas in RA-treated grafts, involucrin staining extended downwards, all the way to the basal layer. Similarly, transglutaminase K staining (Fig 1B) in vehicle-treated skin was found in a compact band immediately below the stratum corneum. RA treatment resulted in increased expression downwards such that the granu lar and part of the spinous layer became positively stained. The increased expression remained restricted to the cell membrane. Immunohistochemical staining for fila ggrin showed a similar expansion (data not shown). Filaggrin and transglutaminase expression patterns did not extend to the basal layer as invo lucrin did.
Quantitative Analysis Quantitative evaluation of the effects of RA treatment on the grafted skin was obtained using a quantitative reverse transcriptase (RT) polymerase chain reaction method developed in our laboratory to measure the induction of the RA-inducible marker, CRABPII [6] . Figure 2 illustrates the results of quantitative RT -PCR analysis of21 skin grafts derived from three patients. The level of CRABPII mRNA in vehicle-treated grafts ranged from 2,4 to 26 attomoljJ.lg with a mean of 12.8 attomoljJ.lg. Data on the abso lute level of CRABPII mRNA in human skin biopsies has been published on three .subjects, and ranged fro~ 15 to 25 attomoljJ.lg [6] . Skin treated WIth 0.01 % RA had essentIally the same level of grafts is in agreement with the range reported for human subjects [6 ,15,19] . Ethanol/propylene glycol vehicle has been established to exert no significant effect on CRABPII expression in human skin [1 8] .
DISCUSSION
The histologic and immunohistochemical analyses carried out in this study demonstrated t hat human skin grafts on nude mice respond to topical RA in a fash ion similar to skin of human volunteers. Transglutaminase K, keratins K1, KlO, and K14, loricrin, and filaggrin are suppressed by RA in keratinocytes cultured on plastic or dermal substrates, whereas involucrin and CRABPII are unaffected [14, 19, 20] ' When these markers were examined in intact skin treated with RA [13] , it was reported that K1, K10, and K14 were unchanged whereas loricrin, filaggrin, involucrin, transglutaminase K, and CRABPII were all increased. Evaluation of RA's effects on K10, K13, involucrin, filaggrin, and transglutaminase K in grafted human skin on nude mice demonstrated that the grafts invariably mimic the response of intact human skin rather than keratinocytes cultured on plastic or dermal substrates. Two major differences between cultured keratinocyte models and ;,' 1 vivo experiments are 1) keratinocytes in intact skin interact with the complex network of epidermal and dermal components, and 2) intact skin presents a barrier through which drug must penetrate. The precise concentration of RA reaching keratinocytes in intact skin has not been measured in published reports. However, the fact that the changes in expression of RA markers differ in direction and not just in extent suggests that keratinocyte interactions with other skin components is the key factor determining the nature of the response.
To demonstrate further the usefulness of such grafts for evaluating drug effects in human skin, we made us e of a quantitative RT-PCR technique. T his method is useful to quantify a specific mRNA from sub-microgram amounts of total RNA obtained from punch biopsies or small skin grafts. In these studies, the RA-inducible marker CRABPII was quantitated from skin grafts treated with various doses of RA.
Our quantitative RT-PCR method makes use of an internal standard consisting of a synthetic RNA ge nerated by in vitro transcription from a CRABPII cDNA construct containing a small deletion in the coding region. A concern in analysis of RNA from skin grafts is the contribution of mouse cells to the healed grafts. It is known that the vascular tissue within such grafts becomes progressively colonized by mouse cells [4] . Total RNA isolated from the grafts may contain both human and mouse RNA. Several precautions were taken to ensure that the RT-PCR quantitation of CRABPII mRNA refl ected levels of human mRNA only. The primer used in the RT reaction was chosen to be specific only for human CRABPII. Specificity was confirmed by demonstrating that the RT and PCR primer combination did not amplify CRABPII mRNA from mouse skin. Furthermore, the total human RNA concentration in preparations of total RNA from grafted skin was determined relative to a standard human RNA by assaying incorporation of nucleotide triphosphates (NTPs) in an RT reaction using a humanspecific primer for G3PDH. This primer did not result in the incorporation of significant levels of radioactive NTPs when mouse RNA was used as a substrate.
With the quantitative PCR method, target genes induced in skin can be measured using punch biopsy-size skin samples, in contrast to standard techniques (Northern blots, RNase protection) , which require large keratome biopsies. Furthermore, the absolute level of mRNA present as well as the fold induction can be measured. In our case, the RT-PCR method was applied to a group of skin grafts originally derived from three reduction mammography patients; the fold induction of the target gene was in good agreement with levels measured using the other methods. The human skin grafted nude mouse model described here required higher concentrations of RA to induce CRABPII than reported recentl y in a detailed study by Elder et aJ in which human volunteers were treated with 0.1 % RA on buttocks skin for up to 4 d [ 1 8 ]. The difference is most likely due to the use of occlusion in the human study, which greatly increases drug penetration. The absolute levels of C~PII mRNA expression in grafts (2.4 to 26 attomol/J.L~) a~e sl~11llar to data we have previously reported from human skm blOpsles (15 to 25 attomol/ J.Lg) and cultured fibroblasts .(24 attomol/J.Lg) [6] . Tl?e low v.alue in the grafted-skin range derives from grafts from a smgle patlent, who may express unusually low levels of CRABPII mRNA; grafts from the remaining two subjects contained 12 to 26 attomol/J.Lg CRABPII mRNA.
The human skin graft model system has potential for use in a broad spectrum of pharmacologic applications. It is possible, using this method, to generate many grafts from skin derived from a single individual and thus test a variety of different drugs or drug concentrations on skin from a single individual, which is usually not possible on human volunteers due to ethical considerations. Human skin grafts have previously been used to examine wound healing [25, 26] and hair growth (in response to cyclosporin [27] ). Results in such studies were obtained in a semi-quantitative fashion (scar formation, counts of growing hairs). As we demonstrated, quantitative PCR analysis is ideally suited for quantifying drug efficacy if suitable markers of drug action can be found; for example, measurements of growth factor receptor levels may be relevant markers for wound healing. One other therapeutic area that might benefit from such a model system is study of the modulation of the inflammatory response. Tumor necrosis factor and interleukin-1 treated grafts have been assayed for leukocyte migration and induction of immunoreactivity for endothelial cell adhesion molecules [28] . Quantitative PCR for adhesion molecules or cytokines could generate additional data in the above system.
The model system described makes it possible to produce a useful in vivo viable human skin model without resorting to a transgenic mouse design. The potential clinical efficacy of pharmacologic agents (such as RA) on human skin can be evaluated with fewer ethical considerations compared to testing with human volunteers. Such grafts may also prove useful for the evaluation of the penetration of drugs in different formulations to optimize drug delivery before undertaking clinical trials.
